My ePortfolio Register   

Editorial Board

Ines Vaz-Luis

Dana-Farber Cancer Institute, Boston, USA

Dr Vaz-Luis is an instructor of Medicine at the Dana-Farber Cancer Institute. Her primary research is centered on the patterns of care and outcomes for breast cancer patients.


She graduated with a medical degree in 2003 from the University of Lisbon and completed her fellowship in medical oncology at the Hospital de Santa Maria, in Lisbon, in 2011. She was also awarded a Career Development Award from the Harvard Medical School-Portugal program the same year.


Dr Vaz-Luis then joined the Breast Oncology Center at the Dana-Farber Cancer Institute and enrolled in the Harvard Medical School Master program Scholars of Clinical Science Program, which she completed in 2013. 

She has been involved in a different range of projects which include outcomes research, clinical trials and translational research. More specifically, she completed studies on patterns of care and outcomes among the National Comprehensive Network among HER2-positive disease and small node negative breast tumors; she is also involved in several projects looking to utilize trastuzumab within Surveillance, Epidemiology and End Results-Medicare. In addition, Dr Vaz-Luis has also examined outcomes among patients with HER2-positive breast cancer within the Dana-Farber Cancer Institute cancer database and was able to identify patients of particular translational interest (e.g. patients with extreme and prolonged responses to trastuzumab therapy). She is also involved in the development of investigator-initiated trials.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence